MR SOLUTIONS is a world leader in MRI technology, developer and manufacturer of the world’s first range of commercial, superconducting, cryogen-free (dry magnet), benchtop MRI systems. MRS accessorizes its preclinical MRI scanners with PET and SPECT modules for both sequential and simultaneous acquisition with MR data.Learn More
MR Solutions announces the first installations of its second generation cryogen free magnet technology for increased scientific capabilities in preclinical MRI
MR Solutions has introduced its second generation MRI magnet technology to its range of ground breaking 3T and 7T, cryogen free, preclinical scanners. Features of this new technology include variable field operation , higher intrinsic magnetic field homogeneity, larger fields of view (FOV) elliptical in shape to better fit the subject and automatic field ramping. This jump in technology has been made possible by MR Solutions’ proprietary technology for optimisation of magnet performance.
MR Solutions featured in LabOutlook: November 2014
MR Solutions is featured in LabOutlook: November 2014 -
Magnifying Results: Preclinical Tech Advances Disease Understanding
Advances in MRI equipment are increasing the quality and range of preclinical research in laboratories.
Our unique MRI system design enables a broad range of applications, from preclinical imaging to food, industrial and commercial applications, offering superior soft tissue contrast and high spatial resolution.Learn More
MRS 7000 – 7.0T Cryogen Free Preclinical MRI
The new 7.0T Cryogen free MRI system Is the latest in our range of revolutionary dry superconducting magnets
Our revolutionary 7.0T, Cryogen Free, Superconducting MRI system, is state-of-the-art, with a small footprint design and light weight (<500kg), suitable for any lab. Liquid Helium Free, Dry Magnet.
MRS 3000 – 3.0T Cryogen Free Preclinical MRI
Truly translational preclinical MRI at 3.0T
Our MRS 3000 series preclinical MRI systems are cost-effective, translational MRI systems, providing superior soft tissue contrast and molecular imaging capability.